These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ferritin levels and hepcidin mRNA expression in peripheral mononuclear cells from anemic type 2 diabetic patients. Andrews M, Arredondo M. Biol Trace Elem Res; 2012 Oct; 149(1):1-4. PubMed ID: 22426798 [Abstract] [Full Text] [Related]
3. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC. Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000 [Abstract] [Full Text] [Related]
4. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Andrews M, Soto N, Arredondo-Olguín M. Nutrition; 2015 Jan; 31(1):51-7. PubMed ID: 25441587 [Abstract] [Full Text] [Related]
8. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J. Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088 [Abstract] [Full Text] [Related]
10. Circulating mononuclear cells in the obese are in a proinflammatory state. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulation; 2004 Sep 21; 110(12):1564-71. PubMed ID: 15364812 [Abstract] [Full Text] [Related]
11. Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes. Mao XM, Liu H, Tao XJ, Yin GP, Li Q, Wang SK. Diabetes Metab Res Rev; 2009 Jul 21; 25(5):435-41. PubMed ID: 19405039 [Abstract] [Full Text] [Related]
12. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. Satoh-Asahara N, Sasaki Y, Wada H, Tochiya M, Iguchi A, Nakagawachi R, Odori S, Kono S, Hasegawa K, Shimatsu A. Metabolism; 2013 Mar 21; 62(3):347-51. PubMed ID: 23062489 [Abstract] [Full Text] [Related]
14. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. Ersoy C, Kiyici S, Budak F, Oral B, Guclu M, Duran C, Selimoglu H, Erturk E, Tuncel E, Imamoglu S. Diabetes Res Clin Pract; 2008 Jul 21; 81(1):56-60. PubMed ID: 18358555 [Abstract] [Full Text] [Related]
15. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s). El-Mesallamy HO, Hamdy NM, Salman TM, Mahmoud S. Minerva Endocrinol; 2011 Sep 21; 36(3):163-70. PubMed ID: 22019747 [Abstract] [Full Text] [Related]
16. Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Mavridis G, Souliou E, Diza E, Symeonidis G, Pastore F, Vassiliou AM, Karamitsos D. Nutr Metab Cardiovasc Dis; 2008 Sep 21; 18(7):471-6. PubMed ID: 17976964 [Abstract] [Full Text] [Related]